Skip to Content

Synovics Pharmaceuticals Inc SYVC

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SYVC is trading at a 17% discount.
Price
$0.00
Fair Value
$5.83
Uncertainty
Extreme
1-Star Price
$1.72
5-Star Price
$7.36
Economic Moat
Myyps
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SYVC is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
/
Market Cap
$2,982.74
Volume/Avg
1,240 / 1,220

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Synovics Pharmaceuticals Inc is a pharmaceutical company, which is engaged in the development, manufacturing and commercialization of generic over the counter pharmaceutical products and generic prescription drug products.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
155
Website

Valuation

Metric
SYVC
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
SYVC
Quick Ratio
0.10
Current Ratio
0.27
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
SYVC
Return on Assets (Normalized)
−23.82%
Return on Equity (Normalized)
−266.82%
Return on Invested Capital (Normalized)
−56.34%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRXcxt$550.4 Bil
VRTX
Vertex Pharmaceuticals IncCkxmw$111.8 Bil
REGN
Regeneron Pharmaceuticals IncNqwwdc$107.9 Bil
MRNA
Moderna IncJms$36.3 Bil
ARGX
argenx SE ADRDfwr$23.0 Bil
BNTX
BioNTech SE ADRFpjz$21.6 Bil
ALNY
Alnylam Pharmaceuticals IncVgmlkd$19.2 Bil
BMRN
Biomarin Pharmaceutical IncPmjybzh$16.4 Bil
RPRX
Royalty Pharma PLC Class AXmxpzf$13.4 Bil
INCY
Incyte CorpTblyj$13.3 Bil

Sponsor Center